ScienceDex / Researcher record
Mark Henderson
- National Center for Advancing Translational Sciences (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2025
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $5.4M in linked award amounts across 21 award records · Award-linked rank #1197.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2025 · selected21 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 77844220Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2025 award records by amount
NIH award records listing Mark Henderson as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000405-06ZIAContact PIHigh-throughput screening to identify inhibitors of breast-to-brain metastasis$418.4Kaward amount
- 1ZIATR000557-01ZIAContact PIGlucocorticoid-antibody conjugates for selective targeting of immune cells$418.4Kaward amount
- 1ZIATR000428-06ZIAContact PIAMPK synthetic activators$348.7Kaward amount
- 1ZIATR000558-01ZIAContact PIScreening for small molecules that extend the shelf life of blood$279Kaward amount
- 1ZIATR000448-04ZIAContact PIDevelopment of a HT-ATACseq assay to identify epigenetic regulators of Ewing Sarcoma cancer cells (Chemical Biology Consortium/NCI Experimental Therapeutics Collaboration)$279Kaward amount
- 1ZIATR000450-04ZIAContact PIIdentification of small molecules that improve trafficking of NLGN4X/Y for autism$279Kaward amount
- 1ZIATR000451-04ZIAContact PIIdentification of small molecule degraders of XPB for inflammatory diseases$279Kaward amount
- 1ZIATR000466-03ZIAContact PIIdentifying LC3 binders to develop lysosome-targeting chimeras$279Kaward amount
- 1ZIATR000504-02ZIAContact PIIdentification of inhibitors of the polyamine transporter ATP13A3$279Kaward amount
- 1ZIATR000505-02ZIAContact PITargeting MSUT2 binding to polyA mRNA for Alzheimer's disease$279Kaward amount
+11 more grants not shown.
Award organization
Organizations that administered FY2025 awards listing Mark Henderson as a PI.
FY2025 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Center for Advancing Translational Sciences
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #1197
- 2025Entered Top 25% NationallyRanked #1197
- 2025Entered Top 10% NationallyRanked #1197